Correction: Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity

por Lee, Ho Jin, Pham, Phuong Chi, Hyun, Seung Yeob, Baek, Byungyeob, Kim, Byungjin, Kim, Yunha, Min, Hye-Young, Lee, Jeeyeon, Lee, Ho-Young
Publicado 2023

Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity

por Lee, Ho Jin, Pham, Phuong Chi, Hyun, Seung Yeob, Baek, Byungyeob, Kim, Byungjin, Kim, Yunha, Min, Hye-Young, Lee, Jeeyeon, Lee, Ho-Young
Publicado 2018

Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor

por Lee, Ho Jin, Pham, Phuong Chi, Pei, Honglan, Lim, Bumhee, Hyun, Seung Yeob, Baek, Byungyeob, Kim, Byungjin, Kim, Yunha, Kim, Min-Hwan, Kang, Nae-Won, Min, Hye-Young, Kim, Dae-Duk, Lee, Jeeyeon, Lee, Ho-Young
Publicado 2021